Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...
The JP Morgan Healthcare Conference is seen as ... It’s not the largest deal announced at a JPM health conference – it’s half the size of Amgen’s $28bn acquisition of Horizon Therapeutics ...
women’s health conversations were not taking place at the JP Morgan health care conference; but now, “there’s an entire track for pursuing investment at the conference” in this space.
The Westin St. Francis, site of the JP Morgan Healthcare Conference in San Francisco ... this survey from Syneos Health has a lot more, including therapeutic areas and IPOs.
Several members of our firm’s life sciences team were on the ground at the 43rd Annual J.P. Morgan Healthcare Conference in ...
Morgan Health launched a few months after J.P. Morgan, Amazon and Berkshire Hathaway disbanded their Haven joint venture.
JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th.
JPMorgan Chase's co-head of global markets, Jason Sippel, is leaving the Wall Street lender and Pranav Thakur has been named ...
SMid Cap Biotechnology Analyst Romero holds a conference call with President & CEO McDonough on February 3 at 1:30 pm hosted by JPMorgan. Published first on TheFly – the ultimate source for real ...